Letter: inflammatory bowel disease services during the Covid-19 pandemic - authors' reply.

Deputy, Mohammed; Hart, Ailsa; Faiz, Omar

Deputy, Mohammed; Hart, Ailsa; Faiz, Omar.

Deputy M; Surgical Epidemiology, Trials and Outcome Centre, St Mark's Hospital and Academic Institute, Harrow, UK.
Hart A; Department of Surgery and Cancer, Imperial College London, London, UK.
Faiz O; Department of Gastroenterology, St Mark's Hospital and Academic Institute, Harrow, UK.

Aliment Pharmacol Ther ; 55(8): 1064, 2022 04.

Article in English | MEDLINE | ID: covidwho-1774742

Subject(s)

COVID-19; Colitis; Inflammatory Bowel Diseases; Chronic Disease; Humans; Inflammatory Bowel Diseases/epidemiology; Inflammatory Bowel Diseases/therapy; Pandemics

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Colitis / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: Aliment Pharmacol Ther Journal subject: Pharmacology / Gastroenterology / Drug Therapy Year: 2022 Document Type: Article Affiliation country: Apt.16884

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google